Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
1.
Life Sci ; 89(11-12): 364-70, 2011 Sep 12.
Artigo em Inglês | MEDLINE | ID: mdl-21806999

RESUMO

AIM: To investigate the effects of shikonin on phorbol myristate acetate (PMA) plus cyclic adenosine monophosphate (cAMP)-induced T helper (T(H)) 2 cell cytokine production, and the underlying mechanism. MAIN METHODS: We used activated EL-4 murine T-lymphoma cells, which produce interleukin (IL)-4 and IL-5, but not interferon (IFN)-γ, as T(H)2 cell-like cells and treated them with PMA+cAMP to investigate the effects of shikonin on T(H)2 cytokines, transcriptional factors, and the related mitogen-activated protein kinase (MAPK)/nuclear factor (NF)-κB signaling pathway. KEY FINDINGS: The data show that shikonin inhibited the PMA+cAMP-induced mRNA and protein expression of IL-4 and IL-5 via the downregulation of GATA-binding protein-3 (GATA-3) and c-musculoaponeurotic fibrosarcoma (Maf) but not T-box expressed in T cells (T-bet). Moreover, shikonin suppressed the phosphorylation of p38, inhibitor of κB (IκB) kinase (IKK)-ß and IκB-α, and the subsequent IκB-α degradation induced by PMA+cAMP; however, the PMA+cAMP-induced phosphorylation of extracellular signal-related kinase (ERK), which resulted in minor inhibition and phosphorylation of c-Jun N-terminal kinase (JNK), seemed to be unaffected by shikonin treatment. SIGNIFICANCE: This study suggests that downregulation of GATA-3 and c-Maf via the suppression of p38, IKK-ß and IκB-α phosphorylation might contribute to the inhibitory effect of shikonin on mitogen-induced IL-4 and IL-5 production in EL-4T cells. Furthermore, shikonin is a potential drug for treating allergic diseases.


Assuntos
Antineoplásicos/farmacologia , Fator de Transcrição GATA3/metabolismo , Interleucina-4/biossíntese , Interleucina-5/biossíntese , Naftoquinonas/farmacologia , Proteínas Proto-Oncogênicas c-maf/metabolismo , Animais , Anti-Inflamatórios não Esteroides/farmacologia , Anti-Inflamatórios não Esteroides/toxicidade , Antineoplásicos/toxicidade , Linhagem Celular Tumoral , Citocinas/biossíntese , Citocinas/genética , Regulação para Baixo , Medicamentos de Ervas Chinesas/farmacologia , Medicamentos de Ervas Chinesas/toxicidade , Quinase I-kappa B/antagonistas & inibidores , Proteínas I-kappa B/antagonistas & inibidores , Interleucina-4/genética , Interleucina-5/genética , Camundongos , Quinases de Proteína Quinase Ativadas por Mitógeno/antagonistas & inibidores , Mitógenos/fisiologia , Naftoquinonas/toxicidade , Linfócitos T/efeitos dos fármacos , Linfócitos T/imunologia
2.
Cell Res ; 20(10): 1148-57, 2010 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-20628369

RESUMO

Animal cells require extrinsic cues for growth, proliferation and survival. The propagation of Drosophila imaginal disc cells in vitro, for example, requires the supplementation of fly extract, the composition of which remains largely undefined. Here I report the biochemical purification of iron-loaded ferritin as an active ingredient of fly extract that is required for promoting the growth of clone 8 imaginal disc cells. Consistent with an essential role for iron-loaded ferritin in cultured cells, overexpression of ferritin or addition of iron in a nutrient-poor diet increases animal viability and body weight, promotes cell proliferation, and shortens the duration of postembryonic development. Conversely, overexpression of dominant-negative ferritin or addition of iron chelator causes the opposite effects. Ferritin mutant flies arrest development at the first-instar larval stage with a severe starvation phenotype reminiscent of that seen in starved larvae. I conclude that iron-loaded ferritin acts as an essential mitogen for cell proliferation and postembryonic development in Drosophila by maintaining iron homeostasis and antagonizing starvation response.


Assuntos
Drosophila/crescimento & desenvolvimento , Ferritinas/fisiologia , Ferro/química , Mitógenos/fisiologia , Animais , Proliferação de Células/efeitos dos fármacos , Drosophila/metabolismo , Desenvolvimento Embrionário/efeitos dos fármacos , Ferritinas/genética , Ferritinas/farmacologia , Quelantes de Ferro/farmacologia , Larva/efeitos dos fármacos , Larva/metabolismo , Mitógenos/farmacologia , Mutação
3.
Eur J Cancer ; 41(13): 1969-79, 2005 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16084079

RESUMO

Eukaryotic cellular machineries including the genome face continuous challenge from environmental deleterious agents, as well as from the by products of their own metabolism. Our skin is the most important barrier. It protects us from xenobiotic and genotoxic agents including ultraviolet (UV) solar radiation and potential carcinogens, which are notorious for causing skin cancer. There is a rise in non-melanoma skin cancer (NMSC), which is diagnosed in more than a million people every year in the United States alone, and is also prevalent in the other Western countries. In addition to sunscreens, chemoprevention of skin cancer by natural non-toxic compounds is suggested as an effective strategy to prevent the incidence of skin cancer. Our extensive animal studies on silibinin, a non-toxic bioactive component in milk thistle, suggest that it has a strong potential to prevent skin cancer incidence, promotion and progression in response to chemical carcinogens and tumour promoters as well as UV radiation. Our data suggest that silibinin has multiple targets in the cell, and can be protective against the harmful effects of cytotoxic agents such as reactive oxygen species and inflammation. Further, silibinin modulates mitogenic and survival signalling, p53, Cip1/p21 and other cell cycle regulatory molecules to prevent UVB-induced skin carcinogenesis. Our ongoing studies also suggest the positive effect of silibinin on the repair of UVB-induced DNA damage in mouse skin. Overall, the protective efficacy of silibinin against skin cancer is supported by sound mechanistic rationale in animal and cell culture studies, and suggests its potential use for humans.


Assuntos
Antineoplásicos/uso terapêutico , Carcinoma/prevenção & controle , Neoplasias Cutâneas/prevenção & controle , Animais , Antineoplásicos/química , Antineoplásicos/farmacologia , Apoptose/fisiologia , Comunicação Celular , Ciclo Celular/efeitos dos fármacos , Proliferação de Células/efeitos dos fármacos , Dano ao DNA/efeitos dos fármacos , Dermatite/prevenção & controle , Humanos , Camundongos , Mitógenos/fisiologia , Silibina , Silimarina/química , Silimarina/farmacologia , Silimarina/uso terapêutico , Proteína Supressora de Tumor p53/metabolismo , Raios Ultravioleta/efeitos adversos
4.
J Nutr ; 131(7): 2021-7, 2001 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-11435524

RESUMO

Because anticancer immunity declines progressively with tumor growth, a major focus of current research in tumor immunology is the development of means to stimulate the host immune system. This study determined the effects of dietary long-chain (n-3) fatty acids and tumor burden on immune cell phospholipid composition and membrane-mediated immune defense in rats implanted with the R3230AC mammary adenocarcinoma. Fischer 344 rats (145 +/- 2 g) were fed one of two semipurified diets (20 g/100 g fat) for 21 d before and 17 d after tumor implantation. Diets provided long-chain (n-3) fatty acids at 0 or 50 g/kg of total fat. Mammary tumor growth was 31% lower (P = 0.1) in rats fed long-chain (n-3) fatty acids. Dietary long-chain (n-3) fatty acids had beneficial effects on several host immune defenses, including activation of CD8(+) T cells and type-1 cytokine (interferon-gamma and tumor necrosis factor-alpha) production (P < 0.05). Upregulated immune function in tumor-bearing rats fed the high (n-3) diet occurred concurrently with specific changes in the major membrane phospholipids phosphatidylcholine and phosphatidylethanolamine in high (n-3)-fed rats. Because membrane composition plays a critical role in immune function, additional work is needed to determine the relationship between alterations in the phospholipid composition of immune cells during cancer and subsequent upregulation of host defense in the tumor-bearing state.


Assuntos
Adenocarcinoma/imunologia , Ácidos Graxos Ômega-3/farmacologia , Ativação Linfocitária/imunologia , Neoplasias Mamárias Experimentais/imunologia , Baço/imunologia , Ração Animal , Animais , Membrana Celular/química , Membrana Celular/efeitos dos fármacos , Citocinas/biossíntese , Feminino , Técnica Indireta de Fluorescência para Anticorpo , Imunofenotipagem , Mitógenos/fisiologia , Fenótipo , Fosfatidiletanolaminas/química , Ratos , Ratos Endogâmicos F344 , Receptores de Interleucina-2/biossíntese , Baço/citologia
5.
Adv Cancer Res ; 77: 1-24, 2000.
Artigo em Inglês | MEDLINE | ID: mdl-10549354

RESUMO

Wingless/Wnt signaling directs cell-fate choices during embryonic development. In Drosophila, Wingless signaling mediates endoderm induction and the establishment of segment polarity in the developing embryo. The fly Wingless cascade is strikingly similar to the vertebrate Wnt signaling pathway, which controls a number of key developmental decisions such as dorsal-ventral patterning in Xenopus. Factors of the TCF/LEF HMG domain family (Tcfs) have recently been established as the downstream effectors of the Wingless/Wnt signal transduction pathways. Upon Wingless/Wnt signaling, a cascade is initiated that results in the accumulation of cytoplasmic beta-catenin (or its fly homolog, Armadillo). There is also a concomitant translocation of beta-catenin/Armadillo to the nucleus, where it interacts with a specific sequence motif at the N terminus of Tcfs to generate a transcriptionally active complex. This bipartite transcription factor is targeted to the upstream regulatory regions of Tcf target genes including Siamois and Nodal related gene-3 in Xenopus, engrailed and Ultrabithorax in Drosophila via the sequence-specific HMG box, and mediates their transcriptional activation by virtue of transactivation domains contributed by beta-catenin/Armadillo. In the absence of Wingless/Wnt signals, a key negative regulator of the pathway, GSK3 beta, is activated, which mediates the downregulation of cytoplasmic beta-catenin/Armadillo via the ubiquitin-proteasome pathway. In the absence of nuclear beta-catenin, the Tcfs recruit the corepressor protein Groucho to the target gene enhancers and actively repress their transcription. An additional corepressor protein, CREB-binding protein (CBP), may also be involved in this repression of Tcf target gene activity. Several other proteins, including adenomatous polyposis coli (APC), GSK3 beta, and Axin/Conductin, are instrumental in the regulation of beta-catenin/Armadillo. In APC-deficient colon carcinoma cell lines, beta-catenin accumulates and is constitutively complexed with nuclear Tcf-4. A proportion of APC wild-type colon carcinomas and melanomas also contains constitutive nuclear Tcf-4/beta-catenin complexes as a result of dominant mutations in the N terminus of beta-catenin that render it insensitive to downregulation by APC, GSK3 beta, and Axin/Conductin. This results in the unregulated expression of Tcf-4 target genes such as c-myc. Based on the established role for Tcf-4 in maintaining intestinal stem cells it is likely that deregulation of c-myc expression as a result of constitutive Tcf-4/beta-catenin activity promotes uncontrolled intestinal cell proliferation. This would readily explain the formation of intestinal polyps during colon carcinogenesis. Similar mechanisms leading to deregulation of Tcf target gene activity are likely to be involved in melanoma and other forms of cancer.


Assuntos
Caderinas/fisiologia , Proteínas do Citoesqueleto/fisiologia , Proteínas de Grupo de Alta Mobilidade/metabolismo , Proteínas Proto-Oncogênicas/fisiologia , Transdução de Sinais , Transativadores , Fatores de Transcrição/metabolismo , Proteínas de Peixe-Zebra , Animais , Padronização Corporal , Neoplasias do Colo/genética , Neoplasias do Colo/fisiopatologia , Drosophila/embriologia , Humanos , Mitógenos/fisiologia , Células Tumorais Cultivadas , Proteínas Wnt , Xenopus/embriologia , Proteínas de Xenopus , beta Catenina
6.
Int J Immunopharmacol ; 17(9): 703-18, 1995 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-8582782

RESUMO

With advanced ageing the zinc pool undergoes progressive reduction as shown by the low zinc plasma levels and the negative crude zinc balance, both in humans and in rodents. It has been suggested that such zinc deficiency might be involved in many age-related immunological dysfunctions, including thymic failure. The relevance of zinc for good functioning of the entire immune system is, at present, well documented. In particular, zinc is required to confer biological activity to one of the best-known thymic peptides, thymulin, which is responsible for cell-mediated immunity. In deep zinc deficiencies, in humans and other animals, the low thymulin levels are due not to a primary failure of the thymus, but to a reduced peripheral saturation of thymic hormones by zinc ions. In aged mice both a reduced peripheral saturation of the hormone and a decreased production by the thymus were present. Oral zinc supplementation in old mice (22 months old) for 1 month induced a complete recovery of crude zinc balance from negative (-1.82) to positive values (+1.47), similar to those of young animals (+1.67). A full recovery of thymic functions with a regrowth of the organ and a partial restoration of the peripheral immune efficiency, as measured by mitogen responsiveness (PHA and ConA) and natural killer cell (NK) activity, were observed after zinc supplementation. These findings clearly pin-point for relevance of zinc for immune efficiency and suggest that the age-related thymic involution and peripheral immunological dysfunctions are not intrinsic and irreversible events but are largely dependent on the altered zinc pool.


Assuntos
Envelhecimento/imunologia , Fator Tímico Circulante/metabolismo , Timo/efeitos dos fármacos , Zinco/administração & dosagem , Administração Oral , Animais , Células Cultivadas , Imuno-Histoquímica , Células Matadoras Naturais/fisiologia , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Mitógenos/fisiologia , Baço/citologia , Subpopulações de Linfócitos T , Timo/imunologia , Timo/patologia , Zinco/sangue , Zinco/deficiência
7.
J Biol Chem ; 269(51): 32558-64, 1994 Dec 23.
Artigo em Inglês | MEDLINE | ID: mdl-7798258

RESUMO

We have investigated the effect of mutations in tyrosines 1131, 1135, and 1136 of the human insulin-like growth factor-I receptor (IGF-IR) on the growth and transformation of mammalian cells. We have used for this purpose R- cells, which are 3T3-like fibroblasts derived from mouse embryos with a targeted disruption of the IGF-IR genes. These cells have no IGF-IR, do not grow in serum-free medium supplemented with the growth factors that sustain the growth of 3T3 cells, and cannot be transformed by simian virus 40 large tumor antigen or other oncogenes. The R- cells were transfected with plasmids expressing: 1) a wild type human IGF-IR cDNA; 2) a receptor with a triple mutation in the above mentioned tyrosines; and 3) receptors with single tyrosine mutations. Cells expressing the wild type or the single tyrosine mutants Y1 (Y1131F) and Y2 (Y1135F) grew in serum-free medium supplemented solely with IGF-I. Cells expressing the triple tyrosine mutant YF or the single mutant Y3 (Y1136F) failed to grow in response to IGF-I only. All mutants, though, failed to form colonies in soft agar, indicating that a fully functional IGF-IR is more critical for anchorage-independent growth than for monolayer growth. The triple mutant expression plasmid also functioned as a dominant negative, inhibiting the growth of wild type cells transformed by the simian virus tumor antigen.


Assuntos
Mitógenos/fisiologia , Mutação , Proteínas Tirosina Quinases/genética , Receptor IGF Tipo 1/fisiologia , Células 3T3 , Animais , Sequência de Bases , Adesão Celular , Divisão Celular , Linhagem Celular , Transformação Celular Neoplásica , Meios de Cultura Livres de Soro , DNA/biossíntese , Primers do DNA , Genes Dominantes , Proteínas Substratos do Receptor de Insulina , Camundongos , Camundongos Knockout , Dados de Sequência Molecular , Fosfoproteínas/metabolismo , Fosforilação , Receptor IGF Tipo 1/genética
8.
Scand J Immunol ; 28(6): 773-82, 1988 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-3266027

RESUMO

A monoclonal antibody, K46M (IgM kappa), obtained after immunization with leucoagglutinin (La)-reactive T-cell surface components, stimulated human lymphocytes to proliferate. It induced maximal proliferation at greater than 20 micrograms IgM/ml after 3-4 days of culture. Cells stimulated by K46M produced interleukin 2 (IL-2) and gamma interferon (IFN-gamma) and expressed receptors for IL-2 and transferrin. The majority of the activated cells were phenotypically T cells as defined by monoclonal antibodies against CD3 and CD2, and an increase in the K46M-positive cells was also observed during the activation period. K46M-activated cells display major histocompatibility complex (MHC)-unrestricted cytotoxicity against several cultured target cells. The frequencies of the cytotoxic and of the proliferative precursor cells were determined using a limiting dilution assay. K46M seems to activate a larger fraction of cytotoxic precursor cells against Molt 4 than against K562, but the statistical significance of these observations requires further exploration. Both K46M or La activated 40% of PBL to proliferate, whereas 70% of PBL were induced by OKT3. However, the frequency of K46M-activated cells was 40% only when the lymphocytes were plated at low cell densities, i.e. less than 0.5 cells per well. At higher densities an inhibition of proliferation was seen that resulted in a biphasic response curve, indicating that the activation of PBL by K46M was not a single hit event. This was not found with either La or OKT3. Whether K46M, in contrast to OKT3 and La, activates a subpopulation with suppressor activity remains to be established.


Assuntos
Anticorpos Monoclonais/fisiologia , Antígenos de Superfície/imunologia , Contagem de Leucócitos , Ativação Linfocitária , Fito-Hemaglutininas/imunologia , Linfócitos T/imunologia , Animais , Testes Imunológicos de Citotoxicidade , Fabaceae , Humanos , Camundongos , Mitógenos/fisiologia , Lectinas de Plantas , Plantas Medicinais , Células-Tronco/imunologia , Linfócitos T Citotóxicos/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA